Results 141 to 150 of about 22,089 (224)

Acute Fulminant Cerebral Edema Caused by Coxsackievirus A6 Infection: A Case Report. [PDF]

Clin Case Rep
An K, Qian J.
europepmc   +1 more source

Full-genome analysis of emerging Coxsackievirus B4 genotype D strains associated with herpangina in eastern China. [PDF]

Microb Genom
Hu X, Sun Y, Xing B, Hu L, Liang Z, Fu J, Liang Y, Chen Y, Li Y, Chen L, Wang L, Wang W, Wang S, Lu Y.   +13 more
europepmc   +1 more source

Personal Log, Stardate 42552.6

Emerging Infectious Diseases, 2010
Curi Kim
doaj   +1 more source

VP1-141 is a determinant of a Vero cell-adapted Coxsackievirus A10 for vaccine development. [PDF]

PLoS Negl Trop Dis
Chen CH, Fang CY, Shen YS, Wang JR, Wu SC, Liu CC.   +5 more
europepmc   +1 more source

Synergistic Lyme Carditis and Coxsackievirus A Myocarditis Presenting With Fulminant Heart Failure. [PDF]

JACC Case Rep
Fahed J, Mohammad A, Zerihun W, Afraz R.
europepmc   +1 more source

Correction: Chang et al. Intertypic Recombination Between Coxsackievirus A16 and Enterovirus A71 Structural and Non-Structural Genes Modulates Virulence and Protection Efficacy. <i>Vaccines</i> 2025, <i>13</i>, 1017. [PDF]

Vaccines (Basel)
Chang HY, Tee HK, Ong KC, Jasni K, Abdullah S, Sam IC, Chan YF.   +6 more
europepmc   +1 more source

Construction of the Multi-Epitope HFMD Vaccine Based on an Attenuated CVB3 Vector and Evaluation of Immunological Responses in Mice. [PDF]

Vaccines (Basel)
Zheng J, Deng H, Liu Z, Zhang H, Liu G, Li Y, Zhu J, Gu L, Qiao D, Wang G, Li R.   +10 more
europepmc   +1 more source

Oncolytic Virotherapy and Immunogenic Cell Death: Mechanisms, Platforms, and Clinical Translation. [PDF]

Viruses
Inoue H.
europepmc   +1 more source

Viral shedding dynamics in coxsackievirus A6 hand, foot, and mouth disease: a prospective, individual-level analysis. [PDF]

BMC Med
Meng J, Cheng Y, Chen Z, Zheng Y, Ding L, Li X, Tsamlag L, Ciren P, Long L.   +8 more
europepmc   +1 more source

The Meningitis and Encephalitis Registry of Lower Saxony, Germany (MERIN) - design and main results of circulating neurotropic pathogen surveillance, 2003 to 2023. [PDF]

Euro Surveill
Wollenweber ML, Beyrer K, Baillot A, Monazahian M, Mertens E, Rettenbacher-Riefler S.   +5 more
europepmc   +1 more source